Pharmaceutical Bioreactor Cleaning SWMS
Biopharmaceutical bioreactor cleaning between batches — CIP cycle execution, manual rinse and inspect, vessel confined-space entry where manual residue removal is required, atmospheric testing, biological exposure control, reactor close-out for sterilisation.
SWMS variants reference your state’s WHS legislation. Instant download after payment.
Pharmaceutical bioreactor cleaning covers the cleaning of a biopharmaceutical bioreactor between production batches — clean-in-place (CIP) cycle execution, manual rinse and inspection, confined-space entry into the vessel where manual residue removal is required, atmospheric testing, biological exposure control, and reactor close-out for sterilisation. The work combines two independent High-Risk Construction Work triggers: entry into the confined bioreactor vessel and work near biological agents in the form of residual product and live cell line. A documented safe system of work is required before the cleaning task that involves vessel entry begins.
A bioreactor vessel is a confined space with a restricted access port, an internal environment that can be oxygen-deficient or hold residual cleaning-agent vapour, and biologically active residue from the cell culture. CIP cycles use caustic and acidic cleaning agents at elevated temperature, and where CIP cannot fully remove residue a worker must enter the vessel to clean it manually, exposing them to the confined-space and biological hazards simultaneously. The confined-space controls follow AS 2865, the biological controls follow the framework for managing biological hazards and the facility's biosafety classification, and the cleaning-agent hazards follow the hazardous-chemicals framework with the relevant safety data sheets.
This SWMS is jurisdiction-neutral within Australia and written to the model WHS framework. Victoria operates under the Occupational Health and Safety Act 2004 and OHS Regulations 2017 — check the VIC-specific variant for the local equivalents of the duties and codes cited here.
Hazards identified
12 hazards covered, sorted by priority.
Asphyxiation in the confined vessel where cleaning-agent vapour, inerting gas, or residual process gas has displaced breathable air.
Chemical burns to skin, eyes, and airway from contact with or vapour from hot caustic and acidic cleaning solutions during CIP and manual cleaning.
Infection, sensitisation, or allergic reaction from contact with biologically active residue, depending on the organism and product handled in the reactor.
Scald, chemical burn, or entanglement if a CIP cycle, agitator, or spray device starts while a worker is inside the vessel.
Inability to self-rescue or be rescued promptly through the restricted access port if the worker is injured or the atmosphere deteriorates.
Thermal burns from hot vessel surfaces and residual hot cleaning solution if entry occurs before cooldown.
Crush, entanglement, or release of pressurised jacket fluid if the mechanical and pressure systems are not isolated before entry.
Sprain, fracture, or fall on the wet, curved internal surfaces of the vessel during manual rinse and inspection.
Musculoskeletal injury manoeuvring cleaning tools and equipment in the cramped vessel interior.
Chemical burns or eye injury from a splash when connecting or disconnecting CIP lines under residual pressure.
Exposure to a residue from a prior batch if the cleaning validation is incomplete, presenting both a product-quality and a worker-exposure issue.
Heat exhaustion working in chemical and biological PPE during an extended manual clean of the vessel.
Control measures
Hierarchy-of-controls order: elimination → substitution → isolation → engineering → administrative → PPE.
- 1Use clean-in-place (CIP) as the primary cleaning method to eliminate or minimise the need for vessel entry, and only enter the vessel for manual cleaning where CIP cannot achieve the validated cleaning standard.
- 2Treat any bioreactor vessel entry as a confined space to AS 2865 — atmospheric test for oxygen, cleaning-agent vapour, and contaminants before and continuously during entry, work to an entry permit, and post a trained stand-by attendant at the access port.
- 3Positively isolate and lock out all energy and process sources before entry — CIP supply, agitator, spray devices, jacket heating and pressure, and any inerting gas — and prove isolation so no system can start or charge while a worker is inside.
- 4Manage the biological hazard to the facility's biosafety classification — inactivate or remove the live cell line and biologically active residue as part of the cleaning sequence, and apply the biological exposure controls and decontamination appropriate to the organism.
- 5Handle CIP caustic and acidic cleaning agents to the hazardous-chemicals framework and their safety data sheets — closed transfer, depressurisation before line disconnection, splash protection, and eyewash and safety showers within reach.
- 6Verify cooldown of the vessel and residual solution to a safe entry temperature before entry, and manage residual heat throughout.
- 7Resource a confined-space rescue plan with trained rescuers and retrieval equipment suited to the restricted access port, so an injured worker can be recovered promptly without relying on delayed external rescue.
- 8Control slips and manual handling inside the vessel with footing measures, mechanical aids where possible, and team handling of cleaning equipment.
- 9Complete and document cleaning validation before close-out to control cross-contamination, integrating the worker-safety and product-quality requirements.
- 10Manage heat stress in PPE with work-rest cycles, ventilation of the vessel, and hydration during prolonged manual cleaning.
- 11Provide PPE as the final layer — chemical-resistant and biological protection, respiratory protection rated for the vapour and biological hazard, eye and splash protection, and atmospheric monitors — selected, fit-tested, and inspected before entry.
- 12Verify confined-space entry, chemical-handling, and biosafety competencies for the crew, and brief every worker on the SWMS, the isolation and decontamination procedures, and the rescue plan before entry.
Applicable Codes of Practice
Becomes legally binding under Section 26A of the WHS Act from 1 July 2026. Governs bioreactor vessel entry — atmospheric testing, entry permits, stand-by attendant, and rescue arrangements.
Becomes legally binding under Section 26A from 1 July 2026. Governs the handling of caustic and acidic CIP cleaning agents, including closed transfer, splash protection, and emergency facilities.
Confined spaces. Provides the technical basis for atmospheric testing, entry permits, stand-by attendants, and rescue arrangements for the vessel entry.
Safety in laboratories — Microbiological safety and containment. Informs the biological exposure controls, containment level, and decontamination practice for the live cell line and biologically active residue.
Becomes legally binding under Section 26A from 1 July 2026. Governs the isolation and proving de-energised of the agitator, CIP, and spray-device drives before vessel entry.
Selection, use and maintenance of respiratory protective equipment. Drives the selection and fit-testing of respiratory protection for cleaning-agent vapour and the biological hazard.
High-Risk Construction Work triggered
The bioreactor vessel is an enclosed space with a restricted access port, not designed for continuous occupancy, with a potential for an oxygen-deficient atmosphere or cleaning-agent vapour. Manual cleaning that requires a worker to enter the vessel is confined-space work under WHS Regulation s. 291.
The vessel holds residual product and a live cell line from the production batch, which are biologically active and can present an infection, sensitisation, or allergic hazard. Cleaning work in proximity to these biological agents satisfies the s. 291 biological-agents trigger alongside the confined-space trigger.
Failure to prepare a SWMS before High-Risk Construction Work commences is a contravention of WHS Regulation s. 291. Category 2 offences under WHS Act s. 32 — where a duty breach exposes a person to a risk of death or serious injury without proof of recklessness — attract substantial monetary penalties for body corporates and individual duty holders; refer to the current SafeWork NSW penalty schedule for the NSW-indexed 2025-26 figures. Category 1 reckless-conduct offences under WHS Act s. 31 attract up to approximately $10.42 million for a body corporate, $2.17 million for an individual PCBU or officer, and $1.04 million for an individual worker, with up to 10 years' imprisonment (NSW-indexed at 1 July 2025). VIC maximum penalties under the Occupational Health and Safety Act 2004 differ in structure and amount and are set at VIC variant-generation time.
Who this is for
- →Biopharmaceutical manufacturers cleaning bioreactors between production batches.
- →Pharmaceutical maintenance and cleaning crews performing manual vessel cleaning where CIP is insufficient.
- →Contract manufacturing organisations operating multi-product bioreactor suites.
- →Pharmaceutical sites requiring a defensible confined-space-and-biological SWMS for vessel entry.
- →Validation and cleaning-service technicians supporting changeover between batches.
What you receive
- ✓Editable Microsoft Word .docx — open in Word or Google Docs, drop in your company logo and ABN.
- ✓State-specific variant matched to the jurisdiction selected at checkout (NSW, VIC, QLD, SA, WA, TAS, NT, or ACT).
- ✓All 12 hazards risk-assessed with inherent and residual ratings against a documented control set.
- ✓Confined-space and biological controls referenced to AS 2865, AS/NZS 2243.3, AS/NZS 1715, and the model codes.
- ✓Reg 291 HRCW breakdown showing the confined-space and biological-agents triggers and the legal duty to prepare the SWMS first.
- ✓CIH-reviewed content written to be defended in front of a site quality lead or a SafeWork inspector.
- ✓Instant download on payment, with a re-download window so you can retrieve the file again if needed.
- ✓Sign-on register and review-log structure ready for site-specific completion by the PCBU.
Worked example
A contract biopharmaceutical manufacturer in Sydney operates a suite of stainless-steel bioreactors producing a monoclonal-antibody cell culture. Between two campaigns, a vessel requires a manual clean because the CIP cycle cannot fully remove a hardened residue at a baffle. Because the manual clean involves vessel entry, the work triggers two High-Risk Construction Work categories — confined space and work near biological agents — and a SWMS is prepared before entry, using this product with the NSW variant. The CIP cycle is run first to inactivate the cell line and remove the bulk of the residue, minimising the time a worker spends in the vessel. Before entry, the CIP supply, the agitator, the spray devices, and the jacket heating and pressure are positively isolated and locked, and the vessel is cooled and tested for oxygen and cleaning-agent vapour. Entry proceeds under permit to AS 2865 with continuous monitoring and a stand-by attendant at the access port, and a rescue plan with retrieval equipment suited to the restricted port is in place. The worker, in chemical and biological PPE selected to the facility's biosafety classification, removes the residual deposit manually, with caustic cleaning agent handled to its safety data sheet and safety showers within reach. Cleaning validation is completed and documented before the vessel is closed out for sterilisation. The clean is completed without a chemical, biological, or atmosphere incident, and the signed SWMS, entry permit, and cleaning-validation records are retained for the batch file and the site's regulatory documentation.
Related legislation
- Work Health and Safety Act 2011 (NSW) — Sections 19 (primary duty of care), 31 (Category 1 offence), 32 (Category 2 offence)
- Work Health and Safety Regulation 2017 (NSW) — Sections 291 (HRCW definition), 299 (SWMS), 66-77 (confined spaces)
- AS 2865-2009 — Confined spaces (atmospheric testing, entry permits, rescue arrangements)
- AS/NZS 2243.3:2022 — Safety in laboratories, Part 3: Microbiological safety and containment
- AS/NZS 1715:2009 — Selection, use and maintenance of respiratory protective equipment
Frequently asked questions
Does every bioreactor clean require this SWMS?
The HRCW SWMS applies specifically where the clean involves entry into the vessel, because that entry is confined-space work and brings the worker into contact with biologically active residue. A clean fully achieved by CIP without entry does not trigger the confined-space category, but the SWMS still sets CIP as the primary method and entry as the exception, with the full controls in place whenever entry is required.
How is the biological hazard controlled before entry?
The live cell line and biologically active residue are inactivated or removed as part of the cleaning sequence before entry, and the biological exposure controls, containment level, and decontamination follow the facility's biosafety classification and AS/NZS 2243.3. The worker enters in biological PPE appropriate to the organism, and the SWMS treats the biological hazard as the second HRCW trigger alongside the confined space.
What stops the CIP or agitator from starting during entry?
All energy and process sources — the CIP supply, the agitator, the spray devices, and the jacket heating and pressure — are positively isolated and locked out before entry, and the isolation is proven. This prevents a scald, chemical burn, or entanglement that would occur if a cycle or mechanism started while a worker is inside the vessel.
Are the CIP cleaning agents a hazard to the worker?
Yes. CIP uses caustic and acidic cleaning agents at elevated temperature, which present chemical-burn and respiratory hazards. The SWMS handles them to the hazardous-chemicals framework and their safety data sheets — closed transfer, depressurisation before disconnection, splash protection, and eyewash and safety showers within reach — and requires the vessel to be cooled before entry.
How does cleaning validation relate to worker safety?
Cleaning validation confirms that residue from the prior batch has been removed to the required standard, which protects both product quality and the worker, since incomplete cleaning leaves a residue the worker could be exposed to. The SWMS requires validation to be completed and documented before close-out, integrating the worker-safety and quality requirements rather than treating them separately.